PLP (139-151) - HCLGKWLGHPDKF
Advantages at a glance
- High-quality products
- Customized solutions
- Personal contact
- Fast service
- Competent technical support +49(0)731-3608-123
| Quantity | Unit price |
|---|---|
| To 2 |
€179.66
|
| From 3 |
€134.75
€179.66
(25% saved)
|
- Free shipping
- Shipping within 24h
- 30 days money back guarantee
- Purchase comfortable on account
Delivery time: 3-8 days
Product information "PLP (139-151) - HCLGKWLGHPDKF"
PLP (139 - 151) - HCLGKWLGHPDKF represents a short peptide sequence of the protein lipid part of the myelin sheath. Such proteins are obviously targets of the immune defense in multiple sclerosis.
Multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS), is characterised by primary demyelination. It is widely thought that this is the result of an autoimmune attack against myelin components. Potential target antigens in MS are proteins of the myelin sheath such as myelin oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and proteolipid protein (PLP). Experimental autoimmune encephalomyelitis (EAE) has proven to be a particularly useful animal model. T cell epitopes of MOG for the induction of EAE in mice have been identified. Several inhibitors of amyloid-beta aggregation have been published. Many of them are fragments and modified peptides derived from the native amyloid-beta sequence. Others were identified by phage display approaches. An overview about peptides that target amyloid-beta is described by Stains et al. (2007) ChemMedChem 2, 1674-1692.
Specifications:
Purity: >95% (HPLC, 214nm)
Sequence: HCLGKWLGHPDKF
Appearance: lyophilized white powder
Quelle / Source:
syntheticKlassifizierungen / Classification
Documents:
CertificateSpec. Product Description
General Data 1
General Data 2
Category List
Source: NCBI PubMed
Hier finden Sie Artikel und Literaturzitate, in denen die Autoren auf die hohe Qualität dieses Genaxxonprodukts vertrauen.
Listed below are articles and references, in which the authors trust in the high quality of this Genaxxon product.
Quelle/Source: NCBI PubMed >
Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation
Jürgen Brück, Julia Holstein, Ivana Glocova, Ursula Seidel, Julia Geisel, Toshio Kanno, Jin Kumagai, Naoko Mato, Stephan Sudowe, Katja Widmaier, Tobias Sinnberg, Amir S. Yazdi, Franziska C. Eberle, Kiyoshi Hirahara, Toshinori Nakayama, Martin Röcken, Kamran Ghoreschi
Sci Rep. 2017; 7: 44482. Published online 2017 Mar 14. doi: 10.1038/srep44482
PMCID: PMC5349589